Low Glycemic Index Diets (With Pulses) in Type 2 Diabetes
Primary Purpose
Type 2 Diabetes
Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Low glycemic index diet with pulses
High Cereal Fibre
Sponsored by

About this trial
This is an interventional treatment trial for Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria: Men and women with type 2 diabetes who
- are treated with oral hypoglycemic agents at a stable dose for at least 8 weeks
- have a HbA1c in the range of 6.5% to 8.5% at screening and at the visit prior to randomization
- have diabetes diagnosed >6 months
- have maintained stable weight for 2 months (within 3%)
- have a valid OHIP card and a family physician
- if prescribed lipid medication, have taken a stable dose for at least 2 weeks
- if prescribed blood pressure medication, have taken a stable dose for at least 1 week
- can keep written food records, with the use of a digital scale
Exclusion Criteria: Individuals who
- take insulin
- take steroids
- have GI disease (gastroparesis, celiac disease, ulcerative colitis, Crohn's Disease, IBS)
- have had a major cardiovascular event (stroke or myocardial infarction) in the past 6 months
- take warfarin (Coumadin)
- have had major surgery in the past 6 months
- have a major debilitating disorder
- have clinically significant liver disease (AST or ALT > 130 U/L), excluding NAFL or NASH
- have hepatitis B or C
- have renal failure (high creatinine > 150 mmol/L)
- have serum triglycerides ≥ 6.0 mmol/L
- have a history of cancer, except non-melanoma skin cancer (basal cell, squamous cell)
- have food allergies to study food components
- have elevated blood pressure (> 145/90) unless approved by GP
- have acute or chronic infections (bacterial or viral)
- have chronic inflammatory diseases (e.g. rheumatoid arthritis, lupus; ulcerative colitis)
- have other conditions which in the opinion of any of the investigators would make them unsuitable for the study
Sites / Locations
- St. Michael's Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Low glycemic Index Diet
High Cereal Fibre Diet
Arm Description
Low glycemic Index Diet, emphasizing pulses
Outcomes
Primary Outcome Measures
change in HbA1c
serum lipids
Secondary Outcome Measures
fasting glucose
change in weight, waist and hip circumference
blood pressure
creatine, urea, and c-peptides in 24 hour urine collection
Full Information
NCT ID
NCT01063361
First Posted
February 3, 2010
Last Updated
December 7, 2015
Sponsor
University of Toronto
Collaborators
Saskatchewan Pulse Growers, Pulse Canada
1. Study Identification
Unique Protocol Identification Number
NCT01063361
Brief Title
Low Glycemic Index Diets (With Pulses) in Type 2 Diabetes
Official Title
Effect of Low Glycemic Index Diets (With Pulses) on Glucose Control in Non-Insulin Dependent Diabetics
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
February 2010 (undefined)
Primary Completion Date
August 2011 (Actual)
Study Completion Date
August 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Toronto
Collaborators
Saskatchewan Pulse Growers, Pulse Canada
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Healthy individuals with type 2 diabetes will receive intensive counseling on food selection to improve glucose control using either high cereal fiber dietary strategies or low glycemic index foods emphasizing dried legumes and their products. The treatments will last 3 months with bloods taken for HbA1c, glucose and blood lipids. If the study shows a benefit for either or both diets, then use of high fiber and/or low glycemic index foods in the diet may provide another potential way to improve glucose control and lower cholesterol levels in non-insulin dependent diabetes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
131 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Low glycemic Index Diet
Arm Type
Experimental
Arm Description
Low glycemic Index Diet, emphasizing pulses
Arm Title
High Cereal Fibre Diet
Arm Type
Active Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Low glycemic index diet with pulses
Intervention Description
Subjects will be advised to follow a diabetic diet, using low glycemic index foods, emphasizing pulses.
Intervention Type
Dietary Supplement
Intervention Name(s)
High Cereal Fibre
Intervention Description
Subjects will be advised to follow a healthy high fibre diabetic diet.
Primary Outcome Measure Information:
Title
change in HbA1c
Time Frame
from prestudy and week 0, to end of treatment weeks 8, 10, and 12
Title
serum lipids
Time Frame
from prestudy and week 0, to end of treatment weeks 8, 10, and 12
Secondary Outcome Measure Information:
Title
fasting glucose
Time Frame
from prestudy and week 0, to end of treatment weeks 8, 10, and 12
Title
change in weight, waist and hip circumference
Time Frame
weeks 0, 12
Title
blood pressure
Time Frame
from prestudy and week 0, to end of treatment weeks 8, 10, and 12
Title
creatine, urea, and c-peptides in 24 hour urine collection
Time Frame
0, 12 weeks.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women with type 2 diabetes who
are treated with oral hypoglycemic agents at a stable dose for at least 8 weeks
have a HbA1c in the range of 6.5% to 8.5% at screening and at the visit prior to randomization
have diabetes diagnosed >6 months
have maintained stable weight for 2 months (within 3%)
have a valid OHIP card and a family physician
if prescribed lipid medication, have taken a stable dose for at least 2 weeks
if prescribed blood pressure medication, have taken a stable dose for at least 1 week
can keep written food records, with the use of a digital scale
Exclusion Criteria: Individuals who
take insulin
take steroids
have GI disease (gastroparesis, celiac disease, ulcerative colitis, Crohn's Disease, IBS)
have had a major cardiovascular event (stroke or myocardial infarction) in the past 6 months
take warfarin (Coumadin)
have had major surgery in the past 6 months
have a major debilitating disorder
have clinically significant liver disease (AST or ALT > 130 U/L), excluding NAFL or NASH
have hepatitis B or C
have renal failure (high creatinine > 150 mmol/L)
have serum triglycerides ≥ 6.0 mmol/L
have a history of cancer, except non-melanoma skin cancer (basal cell, squamous cell)
have food allergies to study food components
have elevated blood pressure (> 145/90) unless approved by GP
have acute or chronic infections (bacterial or viral)
have chronic inflammatory diseases (e.g. rheumatoid arthritis, lupus; ulcerative colitis)
have other conditions which in the opinion of any of the investigators would make them unsuitable for the study
Facility Information:
Facility Name
St. Michael's Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5B 1W8
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
23089999
Citation
Jenkins DJ, Kendall CW, Augustin LS, Mitchell S, Sahye-Pudaruth S, Blanco Mejia S, Chiavaroli L, Mirrahimi A, Ireland C, Bashyam B, Vidgen E, de Souza RJ, Sievenpiper JL, Coveney J, Leiter LA, Josse RG. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med. 2012 Nov 26;172(21):1653-60. doi: 10.1001/2013.jamainternmed.70.
Results Reference
derived
Learn more about this trial
Low Glycemic Index Diets (With Pulses) in Type 2 Diabetes
We'll reach out to this number within 24 hrs